⌘K

Home/Insiders/Avagliano Mark

AM

SEC Insider//CIK 0001783503

Avagliano Mark

CIK 00017835031 companyRESEARCH TRIANGLE PARK, NC

Transactions

14

Companies

1

Filings

6

CIK

0001783503

Recent Transactions

14 trades

Award
G1 Therapeutics, Inc.
Common Stock
2024-09-18+20,600→ 262,645 total
Disposition from Tender
G1 Therapeutics, Inc.
Common Stock
2024-09-18−26,035→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Common Stock
2024-09-18−236,610→ 26,035 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−89,400→ 0 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−41,100→ 0 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-07-05$2.51/sh−2,638→ 242,045 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-07-01+35,000→ 244,683 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-05-13$4.79/sh−8,151→ 209,683 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-03-20+100,000→ 217,834 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-04$2.94/sh−721→ 117,834 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−2,602→ 118,555 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-01-03+44,760→ 121,915 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−758→ 121,157 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2024-01-03+89,400→ 89,400 total

Companies

1

G1 Therapeutics, Inc.
Chief Business Officer

Recent Filings

6

Address

700 PARK OFFICES DRIVE, SUITE 200

RESEARCH TRIANGLE PARK, NC, 27709

View on SEC.gov